Vistagen Therapeutics, Inc. Quarterly Operating Margin in % from Q1 2011 to Q1 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2011 to Q1 2023.
  • Vistagen Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2023 was 26.1K %.
  • Vistagen Therapeutics, Inc. annual Operating Margin for 2022 was 26.1K %.
  • Vistagen Therapeutics, Inc. annual Operating Margin for 2021 was -4.31K %, a 162% decline from 2020.
  • Vistagen Therapeutics, Inc. annual Operating Margin for 2020 was -1.65K %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 26.1K +30.4K Jan 1, 2023 Mar 31, 2023
Q4 2022 17.5K +20K Oct 1, 2022 Dec 31, 2022
Q3 2022 34.7K +36.9K Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.62K -4.05K -259% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.31K -2.66K -162% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.47K -156 -6.74% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.18K +2.5K +53.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.56K Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.65K Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.31K Oct 1, 2020 Dec 31, 2020
Q3 2020 -4.68K Jul 1, 2020 Sep 30, 2020
Q1 2017 -820 Jan 1, 2017 Mar 31, 2017
Q2 2012 -928 -521 -128% Apr 1, 2012 Jun 30, 2012
Q1 2012 -674 -357 -113% Jan 1, 2012 Mar 31, 2012
Q4 2011 -732 Oct 1, 2011 Dec 31, 2011
Q3 2011 -478 Jul 1, 2011 Sep 30, 2011
Q2 2011 -407 Apr 1, 2011 Jun 30, 2011
Q1 2011 -317 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.